The frequency distribution of the ratios of the number of these tumor types to the total number of tumor types with significant survival rates across the 350 genes showed that the lower expression of HIF1A, EP300, EIF5B, COPS5, and RPS3 generally increased the proportion of patients with improved survival (Fig. 4b). This evidence concerns the gene EIF5B and neoplasm.